NCT02954263View on ClinicalTrials.gov

Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

April 30, 2017

Conditions
Healthy Adults, Elderly Subjects
Interventions
DRUG

TD-1439

DRUG

Placebo

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY